Reply to the Letter to the Editor 'Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification' by Hannoun-Levi et al.
作者信息
Franzoi M A, Trapani D, Jezdic S, Regan M M, Curigliano G, Andre F
机构信息
INSERM Unit 981 e Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France.
Department of Medical Oncology, Dana-Farber Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
出版信息
Ann Oncol. 2022 Dec;33(12):1331-1333. doi: 10.1016/j.annonc.2022.09.154. Epub 2022 Sep 15.
PMID:36115609
Abstract
摘要
Zotero 插件